{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:09:16Z","timestamp":1765728556646,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":739,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jacep.2015.08.010","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T14:01:45Z","timestamp":1447164105000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Practice Variation in Triple Therapy for Patients With Both Atrial Fibrillation and Coronary Artery Disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Jason H.","family":"Wasfy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy G.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Maddox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2015.08.010_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2012.06.004","volume":"60","author":"Jneid","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib2","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/hrt.2008.160457","article-title":"Triple antithrombotic management after stent implantation: when and how?","volume":"95","author":"Sch\u00f6mig","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2015.08.010_bib3","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2013.02.001","article-title":"Management of patients with atrial fibrillation (compilation of 2006 ACCF\/AHA\/ESC and 2011 ACCF\/AHA\/HRS recommendations): a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"Anderson","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archinte.1990.00390130089012","article-title":"Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP Project","volume":"150","author":"Chang","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacep.2015.08.010_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/hrt.75.2.200","article-title":"Physician variation in the management of patients with atrial fibrillation","volume":"75","author":"Lip","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.jacep.2015.08.010_bib6","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2015.08.010_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1345\/aph.1R515","article-title":"National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare part D beneficiaries","volume":"47","author":"Raji","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacep.2015.08.010_bib8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacep.2015.08.010_bib9","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial","volume":"65","author":"Fiedler","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jacc.2010.03.043","article-title":"Cardiac performance measure compliance in outpatients: the American College of Cardiology and National Cardiovascular Data Registry\u2019s PINNACLE (Practice Innovation and Clinical Excellence) program","volume":"56","author":"Chan","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib11","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jamainternmed.2013.8198","article-title":"Correlates of repeat lipid testing in patients with coronary heart disease","volume":"173","author":"Virani","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacep.2015.08.010_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/aje\/kwi017","article-title":"Appropriate assessment of\u00a0neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression","volume":"161","author":"Larsen","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2013.09.053","article-title":"Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry)","volume":"63","author":"Maddox","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jacc.2014.10.061","article-title":"Reply: triple therapy for atrial fibrillation and ACS with or without PCI: don\u2019t drop aspirin just yet","volume":"65","author":"Dewilde","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jacc.2014.10.063","article-title":"Triple therapy for atrial fibrillation and ACS with or without PCI: don\u2019t drop aspirin just yet","volume":"65","author":"Capodanno","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib16","first-page":"1335","article-title":"Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome\u2014does everyday medical practice reflects current recommendations? A pilot study","volume":"67","author":"Pelc-Nowicka","year":"2009","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jacep.2015.08.010_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5603\/CJ.a2013.0146","article-title":"Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome in the real world: data from the Berlin AFibACS Registry","volume":"21","author":"Maier","year":"2014","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacep.2015.08.010_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ahj.2007.09.003","article-title":"Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry","volume":"155","author":"Wang","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2015.08.010_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.thromres.2014.01.007","article-title":"CHADS2, CHADS2-VASC, and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"133","author":"Puurunen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacep.2015.08.010_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacep.2015.08.010_bib21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jcin.2012.05.010","article-title":"Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients","volume":"5","author":"Rao","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacep.2015.08.010_bib22","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2015.08.010_bib23","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacep.2015.08.010_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1540-8183.2011.00683.x","article-title":"The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries","volume":"25","author":"Rubboli","year":"2012","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jacep.2015.08.010_bib25","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve of 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2015.08.010_bib26","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1161\/CIRCULATIONAHA.114.013279","article-title":"Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents","volume":"131","author":"Brener","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2015.08.010_bib27","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1161\/CIRCULATIONAHA.114.013281","article-title":"Not all patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy","volume":"131","author":"Becker","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2015.08.010_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1747-0803.2010.00438.x","article-title":"A\u00a0novel approach to gathering and acting on relevant clinical information: SCAMPs","volume":"5","author":"Rathod","year":"2010","journal-title":"Congenit Heart Dis"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X15003692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X15003692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:22:46Z","timestamp":1762500166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X15003692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2405500X15003692"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2015.08.010","relation":{},"ISSN":["2405-500X"],"issn-type":[{"type":"print","value":"2405-500X"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practice Variation in Triple Therapy for Patients With Both Atrial Fibrillation and Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2015.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}